Life Sciences Collaborative
The Life Sciences Collaborative (LSC) is a select group of founders and investors that share a common vision for enhancing the success of emerging businesses in the biotechnology, medtech, and digital health sectors through peer-to-peer learning, connecting and building professional relationships.
The Collaborative has built thriving groups over the last ten years in the Princeton, NJ, Philadelphia/King of Prussia, PA, and most recently in Boston, MA, regions all of which are homes to leading life science innovation clusters.
One of the Collaborative’s great strengths is the opportunity for members to build connections across these key regions
Who we are
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors, and industry service providers who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
The meetings also include presentations by emerging companies, providing them with opportunities to get expert feedback on their technologies and to expand their networks.
Mission Statement
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional development and business growth in the Mid-Atlantic Region.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.
OUR MEMBERS
CEOs, Directors, Private Equity and Venture partners, Angel investors. Members may have successful track record leading public or private companies.
Barb Carlin
VP Finance; Egalet Pharma
Baruch Ben Dor
Ph.D, President and Chief Executive Officer; Infrascan
Bruce Golboro
Chief Financial Officer; OptiNose
Bruno Fontanot
Senior Director, Financial Reporting & Compliance; Nabriva Therapeutics AG
Chris Beck
VP Operations; Formula Pharma
Connie Davies
Principal Consultant; C D Advisory Services
Darshan Kuldarni
Vice President, Regulatory Strategy & Policy; synchrogenix
David Kerr
Vice President Business Development; Syneos Health Commercial Solutions
Erika Geimonen
Vice President, Business Development; Amring Pharmaceuticals
Greg House
Principle; Real World Outcomes LLC
Harry Atkins
Senior Director, Alliance Management; Incyte Corporation
Jack Foster
Vice President of Finance; InClinica, Inc.
Joseph Homan
President; Edspire, Inc.
Keith Goldan
President; Prescia
Matt Handel
President; SkyranBiologics
Motti Attia
Managing Partner; Gesher International Business
Richard Fitzgerald
Chief Financial Officer; Eleven Biotherapeutics